Chongkundang Holdings Corp
KRX:001630
Intrinsic Value
ChongKunDang Holdings Corp. is a business development and investment company, which focuses on pharmaceutical operations. [ Read More ]
The intrinsic value of one Chongkundang Holdings Corp stock under the Base Case scenario is 91 539.52 KRW. Compared to the current market price of 61 000 KRW, Chongkundang Holdings Corp is Undervalued by 33%.
Valuation Backtest
Chongkundang Holdings Corp
Run backtest to discover the historical profit from buying and selling Chongkundang Holdings Corp stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Chongkundang Holdings Corp
Current Assets | 419.7B |
Cash & Short-Term Investments | 81.1B |
Receivables | 132B |
Other Current Assets | 206.5B |
Non-Current Assets | 1T |
Long-Term Investments | 481.7B |
PP&E | 503.9B |
Intangibles | 27.3B |
Other Non-Current Assets | 23.4B |
Current Liabilities | 519.9B |
Accounts Payable | 62.2B |
Accrued Liabilities | 14.2B |
Short-Term Debt | 258.6B |
Other Current Liabilities | 184.9B |
Non-Current Liabilities | 373.1B |
Long-Term Debt | 74.4B |
Other Non-Current Liabilities | 298.7B |
Earnings Waterfall
Chongkundang Holdings Corp
Revenue
|
879.8B
KRW
|
Cost of Revenue
|
-495.9B
KRW
|
Gross Profit
|
383.9B
KRW
|
Operating Expenses
|
-366.4B
KRW
|
Operating Income
|
17.4B
KRW
|
Other Expenses
|
29.6B
KRW
|
Net Income
|
47B
KRW
|
Free Cash Flow Analysis
Chongkundang Holdings Corp
Profitability Score
Profitability Due Diligence
Chongkundang Holdings Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Chongkundang Holdings Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Chongkundang Holdings Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Chongkundang Holdings Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Chongkundang Holdings Corp
According to Wall Street analysts, the average 1-year price target for Chongkundang Holdings Corp is 71 400 KRW with a low forecast of 70 700 KRW and a high forecast of 73 500 KRW.
Shareholder Return
Price
Chongkundang Holdings Corp
Average Annual Return | -2.15% |
Standard Deviation of Annual Returns | 37.74% |
Max Drawdown | -65% |
Market Capitalization | 290.4B KRW |
Shares Outstanding | 4 772 800 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ChongKunDang Holdings Corp. is a business development and investment company, which focuses on pharmaceutical operations. The company is headquartered in Seoul, Seoul. Through its subsidiary, the Company provides pharmaceuticals, including remedies for high blood pressure and high cholesterol, immunosuppressive drugs, antitumor agents, antibiotics, remedies for erectile dysfunction and remedies for obesity. The company also produces antitumor agents, antibiotics, digestives, circulation agents, respiratory agents, remedies for endocrine diseases, remedies for skin diseases, functional cosmetics and others, as well as pharmaceutical ingredients. On November 2, 2013, the Company divested its pharmaceutical business into a newly established wholly owned subsidiary. After the divestiture, the Company engages in the investment and holding business.
Contact
IPO
Employees
Officers
The intrinsic value of one Chongkundang Holdings Corp stock under the Base Case scenario is 91 539.52 KRW.
Compared to the current market price of 61 000 KRW, Chongkundang Holdings Corp is Undervalued by 33%.